» Articles » PMID: 31509716

Changes in Brain Kynurenine Levels Gut Microbiota and Gut-barrier Disruption Induced by Chronic Ethanol Exposure in Mice

Overview
Journal FASEB J
Specialties Biology
Physiology
Date 2019 Sep 12
PMID 31509716
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Inflammatory processes have been shown to modify tryptophan (Trp) metabolism. Gut microbiota appears to play a significant role in the induction of peripheral and central inflammation. Ethanol (EtOH) exposure alters gut permeability, but its effects on Trp metabolism and the involvement of gut microbiota have not been studied. We analyzed several parameters of gut-barrier and of peripheral and central Trp metabolism following 2 different EtOH consumption patterns in mice, the binge model, drinking in the dark (DID), and the chronic intermittent (CI) consumption paradigm. Antibiotic treatment was used to evaluate gut microbiota involvement in the CI model. Mice exposed to CI EtOH intake, but not DID, show bacterial translocation and increased plasma LPS immediately after EtOH removal. Gut-barrier permeability to FITC-dextran is increased by CI, and, furthermore, intestinal epithelial tight-junction (TJ) disruption is observed (decreased expression of zonula occludens 1 and occludin) associated with increased matrix metalloproteinase (MMP)-9 activity and iNOS expression. CI EtOH, but not DID, increases kynurenine (Kyn) levels in plasma and limbic forebrain. Intestinal bacterial decontamination prevents the LPS increase but not the permeability to FITC-dextran, TJ disruption, or the increase in MMP-9 activity and iNOS expression. Although plasma Kyn levels are not affected by antibiotic treatment, the elevation of Kyn in brain is prevented, pointing to an involvement of microbiota in CI EtOH-induced changes in brain Trp metabolism. Additionally, CI EtOH produces depressive-like symptoms of anhedonia, which are prevented by the antibiotic treatment thus pointing to an association between anhedonia and the increase in brain Kyn and to the involvement of gut microbiota.-Giménez-Gómez, P., Pérez-Hernández, M., O'Shea, E., Caso, J. R., Martín-Hernández, D., Cervera, L. A., Centelles. M. L. G.-L., Gutiérrez-Lopez, M. D., Colado, M. I. Changes in brain kynurenine levels gut microbiota and gut-barrier disruption induced by chronic ethanol exposure in mice.

Citing Articles

Prenatal Stress and Ethanol Exposure: Microbiota-Induced Immune Dysregulation and Psychiatric Risks.

Camarini R, Marianno P, Hanampa-Maquera M, Oliveira S, Camara N Int J Mol Sci. 2024; 25(18).

PMID: 39337263 PMC: 11431796. DOI: 10.3390/ijms25189776.


Peripheral inflammation triggering central anxiety through the hippocampal glutamate metabolized receptor 1.

Wang J, Wang Y, Zhu Y, Cui C, Feng T, Huang Q CNS Neurosci Ther. 2024; 30(4):e14723.

PMID: 38676295 PMC: 11053250. DOI: 10.1111/cns.14723.


DSS-induced colitis activates the kynurenine pathway in serum and brain by affecting IDO-1 and gut microbiota.

Zhao L, Wu J, Quan W, Zhou Y, Hong H, Niu G Front Immunol. 2023; 13:1089200.

PMID: 36776388 PMC: 9908955. DOI: 10.3389/fimmu.2022.1089200.


Cyclic Nucleotide Phosphodiesterases in Alcohol Use Disorders: Involving Gut Microbiota.

Hou X, Rong C, Zhang Q, Song S, Cong Y, Zhang H Int J Neuropsychopharmacol. 2022; 26(1):70-79.

PMID: 36087271 PMC: 9850663. DOI: 10.1093/ijnp/pyac060.


Gut microbiota dysbiosis: The potential mechanisms by which alcohol disrupts gut and brain functions.

Chen G, Shi F, Yin W, Guo Y, Liu A, Shuai J Front Microbiol. 2022; 13:916765.

PMID: 35966709 PMC: 9372561. DOI: 10.3389/fmicb.2022.916765.


References
1.
Osterndorff-Kahanek E, Ponomarev I, Blednov Y, Harris R . Gene expression in brain and liver produced by three different regimens of alcohol consumption in mice: comparison with immune activation. PLoS One. 2013; 8(3):e59870. PMC: 3612084. DOI: 10.1371/journal.pone.0059870. View

2.
OConnor J, Lawson M, Andre C, Briley E, Szegedi S, Lestage J . Induction of IDO by bacille Calmette-Guérin is responsible for development of murine depressive-like behavior. J Immunol. 2009; 182(5):3202-12. PMC: 2664258. DOI: 10.4049/jimmunol.0802722. View

3.
Connor T, Starr N, OSullivan J, Harkin A . Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: a role for IFN-gamma?. Neurosci Lett. 2008; 441(1):29-34. DOI: 10.1016/j.neulet.2008.06.007. View

4.
Salazar A, Gonzalez-Rivera B, Redus L, Parrott J, OConnor J . Indoleamine 2,3-dioxygenase mediates anhedonia and anxiety-like behaviors caused by peripheral lipopolysaccharide immune challenge. Horm Behav. 2012; 62(3):202-9. PMC: 3425718. DOI: 10.1016/j.yhbeh.2012.03.010. View

5.
Singer I, Kawka D, Scott S, Weidner J, Mumford R, Riehl T . Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology. 1996; 111(4):871-85. DOI: 10.1016/s0016-5085(96)70055-0. View